Illumina sued Roche again for infringement of NIPT patent

Source: instrument information network may 18, 2015, Illumina filed a lawsuit against ariasa diagnostics and its parent company Roche molecular systems for patent infringement Illumina filed the lawsuit in the Northern District Court of California on May 18, 2015, claiming that ariasa infringed the patent right of "multi-channel nucleic acid reaction" with us patent No 7955794 Illumina believes that ariasa's microarray version of "harmony prenatal test" infringes its NIPT patent In the lawsuit, Illumina noted the description of ariasa's method, including the algorithm for ranking technology and assigning risk scores, which are consistent with the description in the US patent publication Previously, Illumina and its subsidiary, verinata health, infringed the '794 patent and the U.S Patent No 8296076 and No 8318430 in the same court on the "harmony preliminary test" ordered version of ariasa These previous lawsuits are still pending On the day of the application, Illumina said that the infringement technology used in ariasa's microarray version testing method is the technology used in the sequencing version testing method, which shows that the infringement is "intentional act" So I asked the court to award the defendant three times compensation Illumina also asked the court to permanently prohibit the infringement of ariasa and Roche Group.